Ex Vivo Human Placental Transfer of Anti-Human Immunodeficiency Virus Compounds
Objective: The transfer of anti-human immunodeficiency virus (HIV) drugs has been studied in the ex vivo human placental model. There is a paucity of information on the placental transfer of these drugs because of ethical considerations and the expense involved in the use of the non-human primate mo...
Saved in:
Main Author: | Roger E. Bawdon (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
1997-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ex Vivo Human Placental Transfer of Trovafloxacin
by: Brian Casey, et al.
Published: (2000) -
Ex Vivo Human Placental Transfer of Rifampin and Rifabutin
by: Kevin P. Magee, et al.
Published: (1996) -
The Ex Vivo Human Placental Transfer of the Anti-HIV Nucleoside Inhibitor Abacavir and the Protease Inhibitor Amprenavir
by: R. E. Bawdon
Published: (1998) -
Transfer of Meropenem in the ex Vivo Human Placenta perfusion Model
by: Roger E. Bawdon, et al.
Published: (2005) -
Transfer of Meropenem in the ex Vivo Human Placenta perfusion Model
by: Michael Hnat, et al.
Published: (2005)